U.S. pharma large copyright scrapped two experimental weight loss pills last yr—a as soon as-day-to-day capsule, lotiglipron, on account of elevated liver enzymes in addition to a two times-day-to-day capsule, danuglipron, as a result of potent side effects—but CEO Albert Bourla has